Active Comparator: Clinical Diagnosis

OTHER2 trials

Sponsors

AnchorDx Medical Co., Ltd.

Conditions

Bladder CancerUpper Tract Urothelial CarcinomaUrothelial Carcinoma

Unknown Phase

Diagnostic Evaluation of Urine DNA Methylation/Somatic Mutation Profiling for the Detection of Urothelial Carcinoma

CompletedNCT04314245

AnchorDx Medical Co., Ltd.Bladder Cancer, Urothelial Carcinoma

Start: 2019-08-01End: 2022-08-31Updated: 2023-05-24

Diagnostic Evaluation of Urine DNA Methylation/Somatic Mutation Profiling for the Detection of Urothelial Carcinoma

CompletedNCT04314245

AnchorDx Medical Co., Ltd.Bladder Cancer, Urothelial Carcinoma

Start: 2019-08-01End: 2022-08-31Updated: 2023-05-24

Diagnostic Evaluation of Urine DNA Methylation/Somatic Mutation Profiling for Upper Tract Urothelial Carcinoma Detection

AnchorDx Medical Co., Ltd.Upper Tract Urothelial Carcinoma

Start: 2020-09-01End: 2023-12-31Target: 490Updated: 2023-05-24

Related Papers

UriFind assay and association with whole course management of urothelial carcinoma in a large multicentric, prospective China cohort.

Journal of Clinical Oncology2023-06-012 citations